Boeing (BA) stock has fallen roughly 8% over the past year and trades approximately 22% below its 52-week high, even as factory output climbs to levels unseen since 2018.
The disconnect between the shop floor and the stock price defines the central question facing Boeing investors right now heading into the final months of 2026.
Inside the factories, the company is delivering airplanes against a record order book, with the upside case resting on converting that delivery pace into positive free cash flow.
Three months apart, the company’s account of its narrow-body line changed considerably, signaling genuine operational momentum at a business that spent years fighting production instability.
At the first-quarter 2026 report in April, the 737 was stabilized at 42 airplanes per month with the new North Line tooling in place, reflecting a period of careful consolidation before the next push.
By the second-quarter 2026 report in July, the 737 was ramping to 47 per month, and low-rate MAX production had begun on a fourth 737 line, accelerating the trajectory meaningfully.
Management describes that fourth line as the step that unlocks 52 airplanes per month, saying nothing in the supply chain blocks that rate, with comfort resting partly on 737 engines already held in inventory.
The strain is expected to begin between 52 and 57 per month, meaning operational pressure remains manageable in the immediate ramp before tighter constraints take hold at higher output levels.
Demand is clearly not the constraint, as the backlog has reached a record $715 billion, with the commercial unit alone holding more than 6,200 airplanes waiting for delivery.
Revenue over the trailing twelve months stands at $94.0 billion, up 24.8% year over year, yet the operating margin remains negative at -5.4%, meaning volume is arriving well ahead of operating profit.
Free cash flow came in positive at $631 million in the second quarter of 2026, which management attributed to favorable receipt timing, with full-year 2026 guidance set at $1 billion to $3 billion.
The figure management returns to repeatedly is $10 billion in annual free cash flow, which the company says the record backlog makes attainable, though no specific target year has been named.
Reaching that level does not require a new airplane program, as management points to delivery cadence as the primary lever driving improved margins and fixed-cost absorption across more airframes.
Wide-body constraints remain a genuine risk, with Boeing falling behind on 787 engine deliveries in the first half of 2026, and a recovery plan with GE setting the timing for the step to 10 Charleston units per month.
Seat certifications represent a second gating factor, since an airplane can be fully built and still wait on an approved cabin configuration, with management expecting those approvals to run through the remainder of 2026.
Boeing stock has historically moved quickly when conditions align, gaining more than 30% in under two months on 14 separate occasions since 2010, with four of those surges topping 50%.
The most recent such rally occurred in 2026, yet the stock remains down about 8% over the past year, illustrating how sharply sentiment can shift without producing sustained directional gains.
For investors, the setup requires weighing a narrow-body ramp that has largely hit its marks against persistent wide-body supply constraints that continue to limit cash generation from the 787 program.
The core question for BA shareholders is whether the current discount to the 52-week high represents a genuine opportunity or a warning about unresolved structural challenges still embedded in the business.
